Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

Mtech Access host transforming healthcare symposium

• Mtech Access are once again hosting a symposium looking at transforming the healthcare landscape in the UK and how to foster NHS–industry collaboration • Guest speakers from across the...

Petauri Evidence

- PMLiVE

FDA advisory committee recommends Zevra’s arimoclomol for Niemann-Pick disease

The rare genetic disorder affects approximately one in every 100,000 to 120,000 births

- PMLiVE

JCVI announces advice for autumn COVID-19 vaccination programme eligibility

The Committee has advised offering the vaccine to those at high risk of serious disease

- PMLiVE

ALX Oncology’s evorpacept shows promise as gastric cancer combination treatment

More than 6,500 new diagnoses of gastric cancer are made in the UK every year

One person comforting another

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

Cuttsy + Cuttsy

- PMLiVE

The value of medical education in driving commercial success

Onyx Health's Sarah Seilly discusses how innovative, data-driven approaches to medical education and strategic collaborations with HCPs can drive engagement and ensure commercial success in an evolving healthcare industry.

Onyx Health

- PMLiVE

[Free Whitepaper] 6 reasons why direct patient support is a ‘must have’ for your clinical trials

This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽  https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/ 

Innovative Trials

OCP white paper

Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers

Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.

Genesis Research Group

- PMLiVE

Leading the Way at ESC 2024

Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...

Medscape Education

- PMLiVE

WHO and CEPI call for broader research strategy to prepare for future pandemics

They have highlighted the importance of expanding research to entire families of pathogens

- PMLiVE

NewAmsterdam shares positive phase 3 results for CETP inhibitor obicetrapib in HeFH

Heterozygous familial hypercholesterolaemia affects approximately one in 250 people globally

- PMLiVE

FDA grants accelerated approval to Adaptimmune’s Tecelra for synovial sarcoma

Tecelra is now the first engineered cell therapy for a solid tumour cancer in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links